|
Newmark, Kathryn G; O'Reilly, Erin K; Pohlhaus, Jennifer Reineke et al. (2005) Genetic analysis of the requirements for SOS induction by nalidixic acid in Escherichia coli. Gene 356:69-76
|
|
O'Reilly, Erin K; Kreuzer, Kenneth N (2004) Isolation of SOS constitutive mutants of Escherichia coli. J Bacteriol 186:7149-60
|
|
Hong, George; Kreuzer, Kenneth N (2003) Endonuclease cleavage of blocked replication forks: An indirect pathway of DNA damage from antitumor drug-topoisomerase complexes. Proc Natl Acad Sci U S A 100:5046-51
|
|
O'Reilly, Erin K; Kreuzer, Kenneth N (2002) A unique type II topoisomerase mutant that is hypersensitive to a broad range of cleavage-inducing antitumor agents. Biochemistry 41:7989-97
|
|
Kreuzer, K N; Freudenreich, C H; Pommier, Y (2001) Analysis of cleavage complexes using reactive inhibitor derivatives. Methods Mol Biol 95:89-99
|
|
Stohr, B A; Kreuzer, K N (2001) Repair of topoisomerase-mediated DNA damage in bacteriophage T4. Genetics 158:19-28
|
|
Hong, G; Kreuzer, K N (2000) An antitumor drug-induced topoisomerase cleavage complex blocks a bacteriophage T4 replication fork in vivo. Mol Cell Biol 20:594-603
|
|
Kreuzer, K N (2000) Recombination-dependent DNA replication in phage T4. Trends Biochem Sci 25:165-73
|
|
Kreuzer, K N (1998) Bacteriophage T4, a model system for understanding the mechanism of type II topoisomerase inhibitors. Biochim Biophys Acta 1400:339-47
|
|
Freudenreich, C H; Chang, C; Kreuzer, K N (1998) Mutations of the bacteriophage T4 type II DNA topoisomerase that alter sensitivity to antitumor agent 4'-(9-acridinylamino)methanesulfon-m-anisidide and an antibacterial quinolone. Cancer Res 58:1260-7
|
Showing the most recent 10 out of 14 publications
